Different Regulation of Immune Cells in Patients With Preeclampsia
NCT ID: NCT02691364
Last Updated: 2016-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2016-04-30
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanisms of Maternal Immune Tolerance in Early Pregnancy
NCT07297394
Selected Immunological Indicators and Microbiota in Patients With Premature Birth and Preeclampsia
NCT06281262
Role of Anti-C1q Autoantibodies in Pregnancy
NCT06317467
the Implications of Pathogenesis of Pre-Eclampsia
NCT00154934
Cardiac and Immune Cell Function in Preeclampsia
NCT04508582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Healthy women
Blood withdrawal
Preeclamptic
Pregnant women with preeclampsia
Blood withdrawal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood withdrawal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
* 18-40 years
Exclusion Criteria
* immune related disorders (other than preeclampsia)
* fever / illness within the last month
* infertility
* body mass index \<18 or \>30
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jelmer Prins
MD PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/612
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.